| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.008 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |